The use of radiopharmaceuticals has been growing exponentially throughout the world, achieving notable numbers. Recent data estimates that in 2015 the market of Nuclear Medicine and Radiopharmacy surpass the mark of 1.5 trillion dollars, with more than 100 million people making use of these drugs around the world. In this scenario, so overwhelming, is surprising that there has not begun studies of pharmaceutical equivalence and bioequivalence of such drugs, especially with animal model and for therapeutics uses.
Citation: Santos-Oliveira R (2014) Pharmaceutical Equivalence and Bioequivalence of Radiopharmaceuticals: Thinking the Possibility of Generic Radiopharmaceuticals and Preparing for New Technology as Nanotechnology Drugs. J Bioequiv Availab 6:023-023. doi: 10.4172/jbb.1000175